Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AC vs TX Neoadjuvant Chemotherapy in Stage II/III Breast Cancer
NCT00352378Phase 3Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jun 2002
- Primary completion
- Oct 2005
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
01
Overview
A Phase 3 trial of docetaxel, capecitabine in breast cancer, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Jun 2002; status: completed.
02
Drugs
docetaxelcapecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00352378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352378.